Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy

Int J Mol Sci. 2019 Jul 9;20(13):3374. doi: 10.3390/ijms20133374.


An important hallmark in cancer cells is the increase in glucose uptake. GLUT1 is an important target in cancer treatment because cancer cells upregulate GLUT1, a membrane protein that facilitates the basal uptake of glucose in most cell types, to ensure the flux of sugar into metabolic pathways. The dysregulation of GLUT1 is associated with numerous disorders, including cancer and metabolic diseases. There are natural products emerging as a source for inhibitors of glucose uptake, and resveratrol is a molecule of natural origin with many properties that acts as antioxidant and antiproliferative in malignant cells. In the present review, we discuss how GLUT1 is involved in the general scheme of cancer cell metabolism, the mechanism of glucose transport, and the importance of GLUT1 structure to understand the inhibition process. Then, we review the current state-of-the-art of resveratrol and other natural products as GLUT1 inhibitors, focusing on those directed at treating different types of cancer. Targeting GLUT1 activity is a promising strategy for the development of drugs aimed at treating neoplastic growth.

Keywords: GLUT1; cancer metabolism; cancer therapy; glucose uptake inhibition; resveratrol.

Publication types

  • Review

MeSH terms

  • Animals
  • Glucose / metabolism*
  • Glucose Transporter Type 1 / metabolism*
  • Humans
  • Neoplasms / metabolism*
  • Resveratrol / pharmacology*


  • Glucose Transporter Type 1
  • Glucose
  • Resveratrol